EnChannel Medical raised $82.2M in Series B financing, co-led by Dragonball Capital and Lilly Asia Ventures, to accelerate product development and advance clinical trials.
Amount Raised
$82.2 Million
Round Type
Series B
GuangzhouBiotechnologyHealth CareMedicalInvestors
Description
EnChannel Medical, based in Guangzhou, China, closed a Series B financing round, raising $82.2M. The funding will support product development and clinical registration trials globally. The round was co-led by Dragonball Capital and Lilly Asia Ventures. Founded in 2020, EnChannel focuses on innovations in cardiac electrophysiology.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as EnChannel Medical that raised within 45 days of this round, from Fundz verified event records.
- Flomark raised $405K (Seed) on June 12, 2025.
- Cosm Medical raised an undisclosed amount (Seed) on June 5, 2025.
- Canid raised $10M (Series A) on June 3, 2025.
- Femasys raised $1.4M on June 2, 2025.
- Outcomes4Me raised $21M on May 30, 2025.
- MAIA Biotechnology raised $695K (Seed) on May 28, 2025.
Who to call at EnChannel Medical, and when
A new round usually means EnChannel Medical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EnChannel Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EnChannel Medical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EnChannel Medical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EnChannel Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEnChannel Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.